MEDICAMENT CONTAINING AT LEAST ONE PART OF THE UL84 PROTEIN OF THE CYTOMEGALOVIRUS, USE OF POLYPEPTIDES CORRESPONDING TO THE AMINO ACID SEQUENCE OF THE UL84 PROTEIN, AND PROCESS FOR INTRODUCING UL84 INTO TARGET CELLS

摘要

The human cytomegalovirus is an important disease producer in various problem groups like immuno-suppressed patients, new-born children or transplant patients. The publication concerns the use of polypeptides corresponding at least partly to the UL84 sequence as medicaments and the use of the corresponding gene in suitable transfer vectors.